Literature DB >> 30251318

Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity.

Mariam Kayle1, Sharron L Docherty2, Richard Sloane3, Paula Tanabe2, Gary Maslow4, Wei Pan5, Nirmish Shah6.   

Abstract

BACKGROUND: Sickle cell disease (SCD) is a chronic blood disorder in which mortality has increased for adolescents and young adults (AYA). PROCEDURE: A longitudinal analysis of medical records was conducted to describe the clinical course among AYAs (ages 12-27 years) during transition to adult care. Measures included sociodemographic, complications, SCD severity (modified pediatric SCD severity index), comorbidities, and transfer. Group-based trajectory modeling (GBTM) to identify subgroups with distinct severity trajectories and chi-square and unpaired Student t test to explore subgroup differences were used.
RESULTS: Overall, 339 AYAs (97% black, 56% male, 69% hemoglobin SS) had 10 848 clinic, 3840 hospital, and 3152 emergency department visits. Complications included vaso-occlusive crises (80%) and acute chest syndrome (41%). Comorbidities included depression (19%) and anxiety (14%). Most AYAs transferred to adult care (n = 220) at 19 years. Fourteen AYAs died, 10 within seven years from transfer. GBTM identified both stable and increasing severity trajectory groups: stable-low (n = 31, 23%), stable-medium (n = 61, 46%), stable-high (n = 6, 4.5%), low-increasing (n = 13, 10%), and medium-increasing (n = 22, 17%). AYAs with increasing severity (25%) were older, lived closer to the clinic, and had higher risk for SCD complications and comorbidities. They had fewer pediatric clinic visits; however, they were more likely to transfer and remain longer in adult SCD care.
CONCLUSIONS: Whereas most AYAs had stable severity, nearly a quarter had increasing severity, over time. AYAs with increasing severity had more complications, were more likely to transfer to adult care, and demonstrated higher and longer adult SCD care utilization compared with AYAs with stable severity.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescent; complications; severity; sickle cell disease; transition to adult care; young adult

Mesh:

Year:  2018        PMID: 30251318      PMCID: PMC6830445          DOI: 10.1002/pbc.27463

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  12 in total

1.  Analyzing developmental trajectories of distinct but related behaviors: a group-based method.

Authors:  D S Nagin; R E Tremblay
Journal:  Psychol Methods       Date:  2001-03

2.  Key elements for, and indicators of, a successful transition: an international Delphi study.

Authors:  Joan-Carles Suris; Christina Akre
Journal:  J Adolesc Health       Date:  2015-06       Impact factor: 5.012

3.  Group-based trajectory modeling: an overview.

Authors:  Daniel S Nagin
Journal:  Ann Nutr Metab       Date:  2014-11-18       Impact factor: 3.374

Review 4.  Anxiety and depression in children and adolescents with sickle cell disease.

Authors:  Tami D Benton; Judith A Ifeagwu; Kim Smith-Whitley
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

5.  Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study.

Authors:  Jeanette M Jerrell; Avnish Tripathi; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  Improved survival of children and adolescents with sickle cell disease.

Authors:  Charles T Quinn; Zora R Rogers; Timothy L McCavit; George R Buchanan
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

7.  Development and validation of a pediatric severity index for sickle cell patients.

Authors:  Xandra W van den Tweel; Johanna H van der Lee; Harriët Heijboer; Marjolein Peters; Karin Fijnvandraat
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

8.  Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.

Authors:  Deepika S Darbari; Onyinye Onyekwere; Mehdi Nouraie; Caterina P Minniti; Lori Luchtman-Jones; Sohail Rana; Craig Sable; Gregory Ensing; Niti Dham; Andrew Campbell; Manuel Arteta; Mark T Gladwin; Oswaldo Castro; James G Taylor; Gregory J Kato; Victor Gordeuk
Journal:  J Pediatr       Date:  2011-09-03       Impact factor: 4.406

9.  Depression and anxiety in adults with sickle cell disease: the PiSCES project.

Authors:  James L Levenson; Donna K McClish; Bassam A Dahman; Viktor E Bovbjerg; Vanessa de A Citero; Lynne T Penberthy; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Wally R Smith
Journal:  Psychosom Med       Date:  2007-12-24       Impact factor: 4.312

10.  Sickle cell disease related mortality in the United States (1999-2009).

Authors:  Dima Hamideh; Ofelia Alvarez
Journal:  Pediatr Blood Cancer       Date:  2013-04-23       Impact factor: 3.167

View more
  14 in total

1.  Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.

Authors:  Mary E Keenan; Megan Loew; Kristoffer S Berlin; Jason Hodges; Nicole M Alberts; Jane S Hankins; Jerlym S Porter
Journal:  J Pediatr Psychol       Date:  2021-03-18

2.  A program of transition to adult care for sickle cell disease.

Authors:  Anjelica C Saulsberry; Jerlym S Porter; Jane S Hankins
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.

Authors:  Grace Champlin; Scott N Hwang; Andrew Heitzer; Juan Ding; Lisa Jacola; Jeremie H Estepp; Winfred Wang; Kenneth I Ataga; Curtis L Owens; Justin Newman; Allison A King; Robert Davis; Guolian Kang; Jane S Hankins
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-18

4.  Primary care service use during adolescence and young adulthood: Tertiary care cohort affected by chronic health conditions.

Authors:  Kyleigh Schraeder; Alberto Nettel-Aguirre; Andrew S Mackie; Kerry McBrien; Olesya Barrett; Gina Dimitropoulos; Susan Samuel
Journal:  Can Fam Physician       Date:  2022-05       Impact factor: 3.025

5.  Predictors of Distinct Trajectories of Medical Responsibility in Youth with Spina Bifida.

Authors:  Mariam Kayle; David I Chu; Alexa Stern; Wei Pan; Grayson N Holmbeck
Journal:  J Pediatr Psychol       Date:  2020-11-01

6.  Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use.

Authors:  Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657

7.  Cognitive performance as a predictor of healthcare transition in sickle cell disease.

Authors:  Anjelica C Saulsberry-Abate; Marita Partanen; Jerlym S Porter; Pradeep S B Podila; Jason R Hodges; Allison A King; Winfred C Wang; Jane E Schreiber; Xiwen Zhao; Guolian Kang; Lisa M Jacola; Jane S Hankins
Journal:  Br J Haematol       Date:  2021-02-11       Impact factor: 6.998

8.  Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease.

Authors:  Kristen E Howell; Anjelica C Saulsberry-Abate; Joacy G Mathias; Jerlym S Porter; Jason R Hodges; Kenneth I Ataga; Sheila Anderson; Vikki Nolan; Jane S Hankins
Journal:  Pediatr Blood Cancer       Date:  2021-07-19       Impact factor: 3.838

9.  Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.

Authors:  Nicole M Alberts; Sherif M Badawy; Jerlym S Porter; Jane S Hankins; Jason Hodges; Jeremie H Estepp; Chinonyelum Nwosu; Hamda Khan; Matthew P Smeltzer; Ramin Homayouni; Sarah Norell; Lisa Klesges
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-08       Impact factor: 4.773

10.  Radiological Patterns in Sickle Cell Disease Patients with Acute Chest Syndrome: Are There Age-Related Differences?

Authors:  Abdulaziz Mohammad Al-Sharydah; Mohammed Alshahrani; Bander Aldhaferi; Afnan Fahad Al-Muhanna; Hanadi Al-Thani
Journal:  Saudi J Med Med Sci       Date:  2019-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.